McKesson (MCK) Q3 2024 Earnings Call Transcript
MCK earnings call for the period ending December 31, 2023.
Source: yahoo.com
📰 Kesson Venture News
Kesson Venture News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kesson Venture. Real-time updates on events, politics, business and more.
McKesson Corporation (NYSE:MCK) Q3 2024 Earnings Call Transcript
McKesson Corporation (NYSE:MCK) Q3 2024 Earnings Call Transcript February 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $4.42 EPS, expectations were $7.05. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to McKesson’s Third Quarter […]
United States Surgical Solutions Specialty Pharmaceuticals Prescription Technology Solution Sarah Cannon Research Institute Us Oncology Network
Source: yahoo.com
McKesson Corporation (NYSE:MCK) Q3 2024 Earnings Call Transcript
McKesson Corporation misses on earnings expectations. Reported EPS is $4.42 EPS, expectations were $7.05.
Source: insidermonkey.com
Clinical Ink launches Lunexis ePRO+ platform module
Clinical Ink launches Lunexis ePRO+ platform module The clinical trial tech firm has enhanced its electronic patient-reported outcome module, and landed an investment to help promote various technologies. Clinical Ink has announced enhancements to its Lunexis ePRO+ electronic patient-reported outcome module. The module is part of the company’s unified trial technology platform, which reportedly helps streamline implementation and gives both patients and sites the a...
Source: outsourcing-pharma.com